Affordability Of Covid-19 Drugs And Vaccines Shouldn’t Play Second Fiddle To Cost-Effectiveness

This doesn’t mean that resources shouldn’t be spent on developing and eventually paying for coronavirus vaccines or Covid-19 treatments. It does, however, imply that policymakers be made aware of foregone alternative uses of resources.

Read the full post on Forbes - Healthcare